Current Medicinal Chemistry

This journal supports open access

Editor-in-Chief:

Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
UK

Back

PI3K Inhibitors for Cancer Therapy: What has been Achieved So Far?

Volume:16   Issue:8
Pp: 916-930
Peng Wu, Tao Liu and Yongzhou Hu
DOI: 10.2174/092986709787581905

Proteasome Regulators: Activators and Inhibitors

Volume:16   Issue:8
Pp: 931-939
Li Huang and Chin Ho Chen
DOI: 10.2174/092986709787581860

Soluble Forms of RAGE in Human Diseases: Clinical and Therapeutical Implications

Volume:16   Issue:8
Pp: 940-952
Francesca Santilli, Natale Vazzana, Loredana G. Bucciarelli and Giovanni Davi
DOI: 10.2174/092986709787581888

Therapeutic Strategies in the Treatment of Diabetic Nephropathy - a Translational Medicine Approach

Volume:16   Issue:8
Pp: 997-1016
Imtiaz M. Shah, Simon P. Mackay and Gerard A. McKay
DOI: 10.2174/092986709787581897

Agonist-Trafficking and Hallucinogens

Volume:16   Issue:8
Pp: 1017-1027
Javier Gonzalez-Maeso and Stuart C. Sealfon
DOI: 10.2174/092986709787581851

Plasmid-Mediated Quinolone Resistance in Gram-Negative Bacterial Species: An Update

Volume:16   Issue:8
Pp: 1028-1046
Vincent Cattoir and Patrice Nordmann
DOI: 10.2174/092986709787581879